“不确定狼疮抗凝剂”为第三类。

The Korean Journal of Hematology Pub Date : 2012-03-01 Epub Date: 2012-03-28 DOI:10.5045/kjh.2012.47.1.83
Sang Hyuk Park, Seongsoo Jang
{"title":"“不确定狼疮抗凝剂”为第三类。","authors":"Sang Hyuk Park, Seongsoo Jang","doi":"10.5045/kjh.2012.47.1.83","DOIUrl":null,"url":null,"abstract":"TO THE EDITOR: \n \nLaboratory testing for the detection of lupus anticoagulant (LAC) is important for the diagnosis of antiphospholipid syndromes and hypercoagulable states. LACs are heterogeneous circulating autoantibodies directed against epitopes found on negatively charged phospholipids and proteins associated with the cell membrane and inhibit phospholipid-dependent coagulation tests in vitro. However, LAC is actually prothrombotic agents and cause thrombosis in vivo; therefore, accurate diagnosis is critical for risk assessment and long-term patient management with anticoagulants. \n \nTo improve the diagnostic sensitivity of LAC testing, the International Society of Thrombosis and Haemostasis (ISTH) published testing guidelines in 1995 [1], and in 2009, it updated guidelines for LAC detection, patient selection, choice of tests, calculation of cut-off value, and interpretation of results [2]. Although mixing studies are simple in principle, interpretation of their results poses a considerable challenge. The 2009 ISTH guidelines recommended using the 99th percentile of the normal values as a cut-off for determining clotting time correction. When the concentrations of LAC are low, the clotting time after mixing can erroneously return to the normal range, and the results may be interpreted as negative. This shows that low concentrations of LAC cannot be detected when the 99th percentile of the normal values is used as a cut-off. \n \nTherefore, it is necessary to adopt a more stratified diagnostic strategy for LAC, especially for the clotting-time based test, to reduce the possibility of a false-negative result when the concentration of LAC is low. In this context, separate, third strategy should be introduced for individuals with \"indeterminate LAC\". The results can be classified as \"indeterminate LAC\" when the outcomes of both LAC screening and the confirmatory test are positive but that of the mixing test is weakly positive. By introducing \"indeterminate LAC\" as a separate category, we can focus on patients who are thought to have a low concentration of LAC. \n \nAlkayed and Kottke-Marchant reported that indeterminate LAC results were common, and that the clinical characteristics of these individuals differed from those with negative results [3]. In our laboratory, we classify LAC test results into 3 different categories: positive, negative, and indeterminate. Our data also show that patients with \"indeterminate LAC\" have heterogeneous clinical characteristics, from absence of clinical symptoms to evident deep-vein thrombosis, pulmonary thromboembolism, or recurrent fetal loss. If indeterminate LAC results are ignored, these thrombotic diseases may remain undiagnosed. \n \nWe think that adding this third category will prove to be a good strategy both practically and clinically. We completely agree with the opinion of Alkayed and Kottke-Marchant.","PeriodicalId":23001,"journal":{"name":"The Korean Journal of Hematology","volume":"47 1","pages":"83"},"PeriodicalIF":0.0000,"publicationDate":"2012-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5045/kjh.2012.47.1.83","citationCount":"1","resultStr":"{\"title\":\"\\\"Indeterminate lupus anticoagulant\\\" as the third category.\",\"authors\":\"Sang Hyuk Park, Seongsoo Jang\",\"doi\":\"10.5045/kjh.2012.47.1.83\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"TO THE EDITOR: \\n \\nLaboratory testing for the detection of lupus anticoagulant (LAC) is important for the diagnosis of antiphospholipid syndromes and hypercoagulable states. LACs are heterogeneous circulating autoantibodies directed against epitopes found on negatively charged phospholipids and proteins associated with the cell membrane and inhibit phospholipid-dependent coagulation tests in vitro. However, LAC is actually prothrombotic agents and cause thrombosis in vivo; therefore, accurate diagnosis is critical for risk assessment and long-term patient management with anticoagulants. \\n \\nTo improve the diagnostic sensitivity of LAC testing, the International Society of Thrombosis and Haemostasis (ISTH) published testing guidelines in 1995 [1], and in 2009, it updated guidelines for LAC detection, patient selection, choice of tests, calculation of cut-off value, and interpretation of results [2]. Although mixing studies are simple in principle, interpretation of their results poses a considerable challenge. The 2009 ISTH guidelines recommended using the 99th percentile of the normal values as a cut-off for determining clotting time correction. When the concentrations of LAC are low, the clotting time after mixing can erroneously return to the normal range, and the results may be interpreted as negative. This shows that low concentrations of LAC cannot be detected when the 99th percentile of the normal values is used as a cut-off. \\n \\nTherefore, it is necessary to adopt a more stratified diagnostic strategy for LAC, especially for the clotting-time based test, to reduce the possibility of a false-negative result when the concentration of LAC is low. In this context, separate, third strategy should be introduced for individuals with \\\"indeterminate LAC\\\". The results can be classified as \\\"indeterminate LAC\\\" when the outcomes of both LAC screening and the confirmatory test are positive but that of the mixing test is weakly positive. By introducing \\\"indeterminate LAC\\\" as a separate category, we can focus on patients who are thought to have a low concentration of LAC. \\n \\nAlkayed and Kottke-Marchant reported that indeterminate LAC results were common, and that the clinical characteristics of these individuals differed from those with negative results [3]. In our laboratory, we classify LAC test results into 3 different categories: positive, negative, and indeterminate. Our data also show that patients with \\\"indeterminate LAC\\\" have heterogeneous clinical characteristics, from absence of clinical symptoms to evident deep-vein thrombosis, pulmonary thromboembolism, or recurrent fetal loss. If indeterminate LAC results are ignored, these thrombotic diseases may remain undiagnosed. \\n \\nWe think that adding this third category will prove to be a good strategy both practically and clinically. We completely agree with the opinion of Alkayed and Kottke-Marchant.\",\"PeriodicalId\":23001,\"journal\":{\"name\":\"The Korean Journal of Hematology\",\"volume\":\"47 1\",\"pages\":\"83\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.5045/kjh.2012.47.1.83\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Korean Journal of Hematology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5045/kjh.2012.47.1.83\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2012/3/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Korean Journal of Hematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5045/kjh.2012.47.1.83","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/3/28 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
"Indeterminate lupus anticoagulant" as the third category.
TO THE EDITOR: Laboratory testing for the detection of lupus anticoagulant (LAC) is important for the diagnosis of antiphospholipid syndromes and hypercoagulable states. LACs are heterogeneous circulating autoantibodies directed against epitopes found on negatively charged phospholipids and proteins associated with the cell membrane and inhibit phospholipid-dependent coagulation tests in vitro. However, LAC is actually prothrombotic agents and cause thrombosis in vivo; therefore, accurate diagnosis is critical for risk assessment and long-term patient management with anticoagulants. To improve the diagnostic sensitivity of LAC testing, the International Society of Thrombosis and Haemostasis (ISTH) published testing guidelines in 1995 [1], and in 2009, it updated guidelines for LAC detection, patient selection, choice of tests, calculation of cut-off value, and interpretation of results [2]. Although mixing studies are simple in principle, interpretation of their results poses a considerable challenge. The 2009 ISTH guidelines recommended using the 99th percentile of the normal values as a cut-off for determining clotting time correction. When the concentrations of LAC are low, the clotting time after mixing can erroneously return to the normal range, and the results may be interpreted as negative. This shows that low concentrations of LAC cannot be detected when the 99th percentile of the normal values is used as a cut-off. Therefore, it is necessary to adopt a more stratified diagnostic strategy for LAC, especially for the clotting-time based test, to reduce the possibility of a false-negative result when the concentration of LAC is low. In this context, separate, third strategy should be introduced for individuals with "indeterminate LAC". The results can be classified as "indeterminate LAC" when the outcomes of both LAC screening and the confirmatory test are positive but that of the mixing test is weakly positive. By introducing "indeterminate LAC" as a separate category, we can focus on patients who are thought to have a low concentration of LAC. Alkayed and Kottke-Marchant reported that indeterminate LAC results were common, and that the clinical characteristics of these individuals differed from those with negative results [3]. In our laboratory, we classify LAC test results into 3 different categories: positive, negative, and indeterminate. Our data also show that patients with "indeterminate LAC" have heterogeneous clinical characteristics, from absence of clinical symptoms to evident deep-vein thrombosis, pulmonary thromboembolism, or recurrent fetal loss. If indeterminate LAC results are ignored, these thrombotic diseases may remain undiagnosed. We think that adding this third category will prove to be a good strategy both practically and clinically. We completely agree with the opinion of Alkayed and Kottke-Marchant.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Long-term survival of a patient with bone marrow gelatinous degeneration of idiopathic origin. Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells. Prognostic significance of gelsolin and MMP12 in Langerhans cell histiocytosis. Central nervous system (CNS) involvement is a critical prognostic factor for hemophagocytic lymphohistiocytosis. Surgery in patients with congenital factor VII deficiency: A single center experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1